Evidence map›Paper›PMID 30863171›Full record

ArticleCancer management and research2019

Prognostic value of mean platelet volume to plateletcrit ratio in patients with osteosarcoma.

Bo Gou, Hong Cao, Xinghua Cheng, Wei Shang, Mingqing Xu, Wei Qian

Open access · goldAbstract read
In one paragraph

Article in Cancer management and research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bo GouDepartment of Orthopedics, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China, weiqiansy@163.com.
Hong CaoDepartment of Orthopedics, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China, weiqiansy@163.com.
Xinghua ChengDepartment of Orthopedics, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China, weiqiansy@163.com.
Wei ShangDepartment of Orthopedics, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China, weiqiansy@163.com.
Mingqing XuDepartment of Orthopedics, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China, weiqiansy@163.com.
Wei QianDepartment of Orthopedics, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China, weiqiansy@163.com.
Hubei University of Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe objective of this study was to investigate the prognostic value of preoperative mean platelet volume to plateletcrit (MPV/PCT) ratio in patients with osteosarcoma. MATERIALS AND

methodsThe retrospective study included 188 consecutive osteosarcoma patients who experienced neoadjuvant chemotherapy and surgical resection of tumor. The relationships between MPV/PCT and clinicopathological characteristics were analyzed. The Kaplan-Meier analysis and Cox regression proportional hazard model were applied to assess the prognostic value of MPV/PCT ratio.

resultsMPV/PCT ratio was found to be significantly associated with platelet count, platelet distribution width, and PCT (all

conclusionThe high preoperative MPV/PCT ratio may serve as an independent prognostic factor for a favorable prognosis in male osteosarcoma patients. Further studies are needed to confirm the findings.

Indexed as

MPV/PCTosteosarcomaplatelet indicesprognosis

Identifiers

PMID30863171
PMCPMC6388949
OpenAlexW2912504504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.